Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

© 2026 Go Backs. All rights reserved.

Low RiskFDA Vet
Pets & Animals/Pet Medications

Virbac Corporation: Iverhart Plus and Wormshield Chewables Recalled for Sub-potency

Agency Publication Date: June 21, 2013
Share:
Sign in to monitor this recall

Summary

Virbac Corporation is recalling approximately 38 units of Iverhart Plus (ivermectin/pyrantel) and Wormshield (ivermectin/pyrantel) flavored chewables for dogs. Quality testing revealed that specific lots were out of specification due to sub-potent results, meaning the tablets contain less of the active ingredients than required. These medications are intended to prevent heartworm disease and treat intestinal parasites like hookworms and ascarids in dogs. If your dog is currently taking medication from an affected lot, you should contact your veterinarian or pharmacist immediately.

Risk

Because the chewables are sub-potent, they may not provide enough medication to effectively prevent heartworm disease or eliminate intestinal parasites. This could lead to a failure in protection, potentially allowing your pet to develop a serious heartworm infection or maintain a parasitic burden.

What You Should Do

  1. Check your dog's medication packaging for the brand names Iverhart Plus, Wormshield, or Iverhart Plus Puppy Pac.
  2. Identify if your product matches the affected lot numbers: for small dogs (up to 25 lbs), look for Iverhart Plus/Wormshield lots 120844 or 120196, and Puppy Pac lot 120844; for medium dogs, check Worm Shield lots 120202 or 120845 and Iverhart Plus lot 120202; for large dogs, check Iverhart Plus lots 120856, 120076, or 120086.
  3. Contact your veterinarian or pharmacist immediately if you find you have an affected product to discuss testing for heartworm and obtaining a replacement prescription.
  4. Return any unused tablets to the pharmacy or veterinarian where they were purchased for a full refund.
  5. Contact Virbac Corporation for further technical instructions regarding this recall.
  6. For additional information, contact the FDA Center for Veterinary Medicine at 240-402-7002.

Your Remedy Options

💰Full Refund

Refund for sub-potent medication.

How to: Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund.

Affected Products

Product: Iverhart Plus Flavored Chewables for dogs up to 25 lbs (6 tablets)
Model:
0170DS
Lot Numbers:
120844
120196
Product: Wormshield Flavored Chewables for dogs up to 25 lbs (6 tablets)
Model:
0210DS
Lot Numbers:
120844
120196
Product: Iverhart Plus Puppy Pac (1 tablet)
Model:
01800
Lot Numbers:
120844
Product: Worm Shield (ivermectin/pyrantel) Flavored Chewables Medium (6 tablets)
Model:
0210DM
Lot Numbers:
120202
120845
Product: Iverhart Plus (ivermectin/pyrantel) Flavored Chewables Medium (6 tablets)
Model:
0170DM
Lot Numbers:
120202
Product: Iverhart Plus (ivermectin/pyrantel) Flavored Chewables Large (6 tablets)
Model:
0170DL
Lot Numbers:
120856
120076
120086

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 64732
Status: Resolved
Manufacturer: Virbac Corporation
Sold By: Veterinary Clinics; Animal Hospitals; Pharmacies
Manufactured In: United States
Units Affected: 5 products (units with 6 tablets each.; units with 6 tablets each; units with 6 tablets each; units of 10 cards with 6 tablets each; units of 10 cards with 6 tablets each.)
Distributed To: California, Florida, Hawaii, Iowa, Indiana, Kansas, Maryland, Michigan, Minnesota, Missouri, Mississippi, Nebraska, New Jersey, New Mexico, Oklahoma, Oregon, Pennsylvania, Tennessee, Texas, Wisconsin

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response